Presentation Cell Therapy 2013 Cardiac-derived Stem Cells Post-MI: CADUCEUS and ALLSTAR Presenter: Eduardo Marb?n January 22, 2013 REGISTER for free or LOG IN to view this content Coronary Presentation Cell Therapy 2013 Up Next Presentation Cell Therapy 2013 Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem Presenter: Kenneth M. Borow January 22, 2013 More slides + Presentation Cell Therapy 2013 SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study Presenter: Marc S. Penn January 22, 2013 Presentation Cell Therapy 2013 Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells Presenter: Kenneth Borow January 22, 2013 We Recommend
Presentation Cell Therapy 2013 Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem Presenter: Kenneth M. Borow January 22, 2013
Presentation Cell Therapy 2013 SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study Presenter: Marc S. Penn January 22, 2013
Presentation Cell Therapy 2013 Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells Presenter: Kenneth Borow January 22, 2013